Cessation of NSAIDs and ETOH
Eradicate H. pylori if identified in symptomatic patient
Triple Therapy: PPI + clarithromycin 500mg BID + amoxicillin1g BID x 10-14d
Metronidazole 500mg BID can be substituted for amoxicillin in penicillin-allergic individuals
Quadruple Therapy:  PPI + bismuth subsalicylate 524mg QID + metronidazole 250mg QID and tetracycline 500mg QID x 10-14d.
Can be used in areas of high resistance to clarithromycin or metronidazole
Triple Therapy: PPI + clarithromycin 500mg BID + amoxicillin1g BID x 10-14d
Metronidazole 500mg BID can be substituted for amoxicillin in penicillin-allergic individuals
Quadruple Therapy:  PPI + bismuth subsalicylate 524mg QID + metronidazole 250mg QID and tetracycline 500mg QID x 10-14d.
Can be used in areas of high resistance to clarithromycin or metronidazole
Metronidazole 500mg BID can be substituted for amoxicillin in penicillin-allergic individuals
Can be used in areas of high resistance to clarithromycin or metronidazole
PPI
Generally heal ulcers faster than H2 blockers
Omeprazole 20-40mg QD
H2 blockers
Famotidine 20-40mg QD
Ranitidine 75-150mg BID
Generally heal ulcers faster than H2 blockers
Omeprazole 20-40mg QD
Famotidine 20-40mg QD
Ranitidine 75-150mg BID
Gastritis
Gastroesophageal reflux disease 
Colitis
Peptic ulcer disease with or without perforation
Pharyngitis
Laryngitis
Pancreatitis
Conjunctivitis